The demand for magnetic resonance imaging (MRI) in pediatric patients is increasing due to its use in medical diagnosis and surveillance. Pediatric patients often require general anesthesia (GA) for MRI due to the need for prolonged immobility during the scanning process to obtain high quality images. Two widely used anesthetic techniques for pediatric MRIs are volatile-based anesthesia using sevoflurane and total intravenous anesthesia (TIVA) using propofol. Concerns have been raised regarding the potential neurotoxic effects of anesthetics on the developing brain. Within the animal literature, there is emerging evidence to suggest that both sevoflurane and propofol may cause inflammation, impacting brain cell survival and connections, thereby contributing to possible cognitive dysfunction. However, given the challenges in extrapolating the animal data to humans, and the relatively limited human cohort studies examining the long-term effects of anesthesia exposure, there is inadequate information available to make informed clinical decisions regarding the choice of optimal anesthetic agents for MRI in children. Therefore, this study will uniquely examine the mechanisms of two widely used anesthetics and their short and long-term impact on developmental outcomes in healthy children.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
50
The child will be randomized via a block design to receive either a volatile anesthetic (induction: sevoflurane), or total intravenous anesthetic technique (induction: propofol)
The child will be randomized via a block design to receive either a volatile anesthetic (induction: sevoflurane), or total intravenous anesthetic technique (induction: propofol)
Each patient will receive Ametop local anesthetic to the dorsum of both hands 30-45 minutes prior to induction.
Each patient will receive the antiemetic ondansetron 0.1mg/kg IV.
University of Calgary
Calgary, Alberta, Canada
Wechsler Preschool and Primary Scale of Intelligence (WPPSI-IV)
The WPPSI - IV is designed for children aged 2.5 to 7.5 years, and is used to assess general intelligence.
Time frame: 12-15 weeks from date of randomization
The Child Behavior Checklist (CBCL) 1.5 to 5 years
The CBCL is widely used for identifying problem behaviors in children ages 1.5 to 5 years
Time frame: Change from baseline at 12-13 weeks after randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.